Publication: Uric acid enhances alteplase-mediated thrombolysis as an antioxidant
Issued Date
2018-12-01
Resource Type
ISSN
20452322
Other identifier(s)
2-s2.0-85055612461
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Scientific Reports. Vol.8, No.1 (2018)
Suggested Citation
Kiyoshi Kikuchi, Kentaro Setoyama, Eiichiro Tanaka, Shotaro Otsuka, Takuto Terashi, Kazuki Nakanishi, Seiya Takada, Harutoshi Sakakima, Sumate Ampawong, Ko ichi Kawahara, Tomoka Nagasato, Kazuya Hosokawa, Yoichiro Harada, Mika Yamamoto, Chinatsu Kamikokuryo, Ryoji Kiyama, Motohiro Morioka, Takashi Ito, Ikuro Maruyama, Salunya Tancharoen Uric acid enhances alteplase-mediated thrombolysis as an antioxidant. Scientific Reports. Vol.8, No.1 (2018). doi:10.1038/s41598-018-34220-1 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/47490
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Uric acid enhances alteplase-mediated thrombolysis as an antioxidant
Author(s)
Kiyoshi Kikuchi
Kentaro Setoyama
Eiichiro Tanaka
Shotaro Otsuka
Takuto Terashi
Kazuki Nakanishi
Seiya Takada
Harutoshi Sakakima
Sumate Ampawong
Ko ichi Kawahara
Tomoka Nagasato
Kazuya Hosokawa
Yoichiro Harada
Mika Yamamoto
Chinatsu Kamikokuryo
Ryoji Kiyama
Motohiro Morioka
Takashi Ito
Ikuro Maruyama
Salunya Tancharoen
Kentaro Setoyama
Eiichiro Tanaka
Shotaro Otsuka
Takuto Terashi
Kazuki Nakanishi
Seiya Takada
Harutoshi Sakakima
Sumate Ampawong
Ko ichi Kawahara
Tomoka Nagasato
Kazuya Hosokawa
Yoichiro Harada
Mika Yamamoto
Chinatsu Kamikokuryo
Ryoji Kiyama
Motohiro Morioka
Takashi Ito
Ikuro Maruyama
Salunya Tancharoen
Abstract
© 2018, The Author(s). Uric acid (UA) therapy may prevent early ischemic worsening after acute stroke in thrombolysis patients. The aim of this study was to examine the influence of UA on the thrombolytic efficacy of alteplase in human blood samples by measuring thrombolysis under flow conditions using a newly developed microchip-based flow-chamber assay. Human blood samples from healthy volunteers were exposed to UA, alteplase, or a combination of UA and alteplase. Whole blood and platelet-rich plasma were perfused over a collagen- and thromboplastin-coated microchip, and capillary occlusion was monitored with a video microscope and flow-pressure sensor. The area under the curve (extent of thrombogenesis or thrombolysis) at 30 minutes was 92% lower in the UA–alteplase-treated group compared with the alteplase-treated group. D-dimers were measured to evaluate these effects in human platelet-poor plasma samples. Although hydrogen peroxide significantly decreased the elevation of D-dimers by alteplase, UA significantly inhibited the effect of hydrogen peroxide. Meanwhile, rat models of thromboembolic cerebral ischemia were treated with either alteplase or UA–alteplase combination therapy. Compared with alteplase alone, the combination therapy reduced the infarct volume and inhibited haemorrhagic transformation. UA enhances alteplase-mediated thrombolysis, potentially by preventing oxidative stress, which inhibits fibrinolysis by alteplase in thrombi.